|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.27 USD | +4.21% |
|
+2.65% | +6.95% |
| 07-03 | Trial for Ebola treatment starts in DR Congo | RE |
| 07-02 | Trial for Bundibugyo Ebola treatment starts in DRC, WHO says | RE |
Chart calendar Gilead Sciences, Inc.
Upcoming events on Gilead Sciences, Inc.
No events available
Past events on Gilead Sciences, Inc.
| 2026-05-07 | Earnings release - Q1 2026 | |
| 2026-05-07 | Earnings presentation | 16:30 |
| 2026-04-30 | Présentation aux Actionnaires / Analystes | 13:00 |
| 2026-04-29 | Annual General Meeting | |
| 2026-04-07 | Information meeting | 16:30 |
| 2026-02-10 | Earnings presentation | 16:30 |
| 2026-02-10 | Earnings release - Q4 2025 | |
| 2025-10-30 | Earnings release - Q3 2025 | |
| 2025-10-30 | Earnings presentation | 16:30 |
| 2025-08-07 | Earnings release - Q2 2025 | |
| 2025-08-07 | Earnings presentation | 16:30 |
Past dividends on Gilead Sciences, Inc.
| 2026-06-15 | Ex-dividend date - 0.82 USD | 00:00 |
| 2026-03-13 | Ex-dividend date - 0.82 USD | 00:00 |
| 2025-12-15 | Ex-dividend date - 0.79 USD | 00:00 |
| 2025-09-15 | Ex-dividend date - 0.79 USD | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 27 116 27 083 0.12% | 28 754 28 310 1.57% | 29 443 29 205 0.82% | 30 465 | 32 359 | 34 108 |
|
EBITDA Million USD | Released Forecast Spread | 13 177 13 123 0.41% | 11 287 10 600 6.49% | 15 953 15 971 -0.11% | 5 484 | 17 828 | 18 171 |
|
EBIT Million USD | Released Forecast Spread | 10 484 10 687 -1.9% | 8 520 8 238 3.42% | 13 193 13 223 -0.23% | 2 729 | 15 524 | 16 583 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 859 7 323 -6.33% | 690 498 38.57% | 9 796 10 031 -2.34% | -810 | 12 021 | 12 892 |
|
Net income Million USD | Released Forecast Spread | 5 665 5 872 -3.52% | 480 282 70.44% | 8 510 8 235 3.34% | -3 373 | 9 548 | 10 218 |
|
EPS USD | Released Forecast Spread | 4,50 4,69 -3.96% | 0,38 0,10 274.46% | 6,78 6,82 -0.56% | -2,80 | 7,67 | 8,28 |
| Announcement Date | 06/02/24 | 11/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7 545 6 999 7.8% | 7 569 7 154 5.8% | 6 667 6 813 -2.14% | 7 082 6 964 1.69% | 7 769 7 459 4.16% | 7 925 7 681 3.18% | 6 960 6 938 0.32% | 7 412 | 7 802 | 8 235 | 7 312 | 7 700 | 8 008 | 8 498 |
|
EBITDA Million USD | Released Forecast Spread | 3 948 3 498 12.86% | 3 807 3 255 16.94% | 3 589 3 423 4.85% | 3 981 4 110 -3.13% | 4 607 4 587 0.44% | 3 776 4 359 -13.38% | 3 956 3 557 11.2% | -7 516 | 4 366 | 4 462 | ||||
|
EBIT Million USD | Released Forecast Spread | 3 258 2 721 19.75% | 3 114 2 876 8.27% | 2 893 2 825 2.4% | 3 290 3 235 1.71% | 3 921 3 482 12.6% | 3 089 3 072 0.55% | 3 267 3 093 5.62% | -7 600 | 3 401 | 3 602 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 956 1 652 -42.12% | 2 168 2 043 6.14% | 1 649 2 068 -20.24% | 2 429 2 355 3.14% | 3 641 2 628 38.56% | 2 078 2 338 -11.11% | 2 580 2 236 15.38% | -8 918 | 2 493 | 2 944 | ||||
|
Net income Million USD | Released Forecast Spread | 1 253 1 335 -6.15% | 1 783 1 605 11.1% | 1 315 1 533 -14.2% | 1 960 1 898 3.24% | 3 052 2 098 45.48% | 2 183 1 819 20% | 2 021 1 944 3.95% | -8 600 | 1 024 | 2 014 | ||||
|
EPS USD | Released Forecast Spread | 1,00 1,08 -7.48% | 1,42 1,19 19.08% | 1,04 1,26 -17.23% | 1,56 1,48 5.12% | 2,43 1,69 43.48% | 1,74 1,54 12.68% | 1,61 1,58 1.86% | -7,29 | 1,20 | 1,64 | 1,72 | 1,82 | 2,04 | 1,89 |
| Announcement Date | 06/11/24 | 11/02/25 | 24/04/25 | 07/08/25 | 30/10/25 | 10/02/26 | 07/05/26 | - | - | - | - | - | - | - |
| 2026-07-06 |  | Information meeting | 10:30 |
| 2026-07-07 | | Ex-dividend date - 0.29903 HKD | 00:00 |
| 2026-07-07 | | Présentation aux Actionnaires / Analystes | 00:30 |
| 2026-07-08 | | Extraordinary General Meeting | 08:00 |
| 2026-07-08 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-07-09 | | Significant Split/Dividend | 00:00 |
| 2026-07-10 | | Ex-dividend date - 8 INR | 00:00 |
| 2026-07-10 | | Extraordinary General Meeting | 02:00 |
| 2026-07-10 | | Extraordinary General Meeting | 02:00 |
| 2026-07-10 | | Ex-dividend date - 0.17248 HKD | 00:00 |
Past sector events for Gilead Sciences, Inc.
| 2026-07-03 | | Ex-dividend date - 0.2 HKD | 00:00 |
| 2026-07-03 | | Board of Directors Meeting | 01:45 |
| 2026-07-03 | | Ex-dividend date - 1 INR | 00:00 |
| 2026-07-03 | | Ex-dividend date for special dividend - 2 INR | 00:00 |
| 2026-07-03 | | Ex-dividend date - 0.37 CNY | 00:00 |
| 2026-07-02 | | Ex-dividend date - 0.63 USD | 00:00 |
| 2026-07-02 | | Annual General Meeting | 05:30 |
| 2026-07-02 | | Présentation aux Actionnaires / Analystes | 05:30 |
| 2026-07-02 | | Présentation aux Actionnaires / Analystes | |
| 2026-07-02 | | Annual General Meeting | 10:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- Calendar Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
